Margaret Martin is named as a lobbyist on federal disclosure filings for 16 clients through Dla Piper LLP (us). The most recent filing naming them posted in October 2026. Issues reported include Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid and Pharmacy.
Filers must list covered executive or legislative branch positions held. As filed:
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| IRA WATCHDOG | DLA PIPER LLP (US) | Q3 2026 | Medicare/Medicaid, Medical/Disease Research/Clinical Labs |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | DLA PIPER LLP (US) | Q3 2026 | Trade (domestic/foreign), Budget/Appropriations, Medicare/Medicaid |
| BIOGEN, INC. | DLA PIPER LLP (US) | Q3 2026 | Trade (domestic/foreign), Medical/Disease Research/Clinical Labs, Taxation/Internal Revenue Code |
| COALITION FOR SMARTER REGULATION OF NICOTINE | DLA PIPER LLP (US) | Q3 2026 | Tobacco, Health Issues, Budget/Appropriations |
| BIONJ, INC. | DLA PIPER LLP (US) | Q3 2026 | Health Issues |
| NOVARTIS | DLA PIPER LLP (US) | Q3 2026 | Trade (domestic/foreign), Medical/Disease Research/Clinical Labs, Taxation/Internal Revenue Code |
| REGENXBIO INC. | DLA PIPER LLP (US) | Q3 2026 | Medical/Disease Research/Clinical Labs, Health Issues |
| AVALYN PHARMA INC. | DLA PIPER LLP (US) | Q3 2026 | Medical/Disease Research/Clinical Labs, Health Issues |
| PRELUDE CORPORATION (PRELUDEDX) | DLA PIPER LLP (US) | Q3 2026 | Medicare/Medicaid, Health Issues |
| ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) | DLA PIPER LLP (US) | Q3 2026 | Medicare/Medicaid, Medical/Disease Research/Clinical Labs |
| BIOTECHNOLOGY INNOVATION ORGANIZATION | DLA PIPER LLP (US) | Q3 2026 | Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Pharmacy |
| AIDOC, INC. | DLA PIPER LLP (US) | Q1 2026 | Medicare/Medicaid, Health Issues |
| DUKE UNIVERSITY HEALTH SYSTEM | DLA PIPER LLP (US) | Q4 2025 | Health Issues |
| CALIFORNIA APARTMENT ASSOCIATION | DLA PIPER LLP (US) | Q4 2025 | Pharmacy |
| CURRAX PHARMACEUTICALS LLC | DLA PIPER LLP (US) | Q2 2025 | Pharmacy |
| WE WORK FOR HEALTH | DLA PIPER LLP (US) | Q1 2025 | Health Issues |
| Year | Clients | Registrants |
|---|---|---|
| 2026 | 12 | 1 |
| 2025 | 16 | 1 |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Margaret Martin. See the Capitol Clarity rankings and method.